Chemokine, vascular and therapeutic effects of combination Simvastatin and BMSC treatment of stroke.
Chemokine, vascular and therapeutic effects of combination Simvastatin and BMSC treatment of stroke.
复制标题
DOI:
10.1016/j.nbd.2009.06.012
复制
发表时间:
2009-10
影响因子:
6.1
通讯作者:
Chen J
中科院分区:
文献类型:
--
作者:
Cui X;Chopp M;Zacharek A;Roberts C;Lu M;Savant-Bhonsale S;Chen J
We investigated the additive therapeutic effect that combination treatment of stroke with sub-therapeutic doses of Simvastatin, a HMG-CoA reductase inhibitor, and bone marrow stromal cells (BMSCs). Rats were administered Simvastatin (0.5 mg/kg), BMSCs (1×106) or combination Simvastatin with BMSCs starting at 24 hours after stroke. Combination treatment significantly improved neurological outcome, enhanced angiogenesis and arteriogenesis, and increased the number of engrafted-BMSCs in the ischemic brain. The number of engrafted-BMSCs and arteriogenesis were significantly correlated with functional outcome. Simvastatin significantly increased stromal cell-derived factor-1 (SDF1) expression in the ischemic brain and chemokine (CXC motif) receptor-4 (CXCR4) in BMSCs, and increased BMSC migration to RBMECs and astrocytes. Combination treatment of stroke upregulates the SDF1/CXCR4 axis and enhances BMSC migration into the ischemic brain, amplifies arteriogenesis and angiogenesis, and improves functional outcome after stroke.
登录
查看更多内容
影响因子:
20.1
作者:
Chen, JL;Zhang, ZG;Chopp, M
通讯作者:
Chopp, M
影响因子:
6.3
作者:
Chen, JL;Zhang, CL;Chopp, M
通讯作者:
Chopp, M
影响因子:
2.9
作者:
Borlongan, CV;Lind, JG;Hess, DC
通讯作者:
Hess, DC
DOI:
10.1161/atvbaha.107.145573
发表时间:
2008-01-01
影响因子:
8.7
作者:
Madeddu, Paolo;Kraenkel, Nicolle;Hirsch, Emilio
通讯作者:
Hirsch, Emilio
DOI:
10.1111/j.1582-4934.2006.tb00290.x
发表时间:
2006-01
影响因子:
5.3
作者:
Heil M;Eitenmüller I;Schmitz-Rixen T;Schaper W
通讯作者:
Schaper W